STOCKHOLM, Jan. 5, 2021 /PRNewswire/ -- IRRAS AB, a
commercial-stage medical technology company with a comprehensive
portfolio of innovative products for neurocritical care, today
announced that Kleanthis G.
Xanthopoulos, Ph.D., the company's Chief Executive Officer,
and Will Martin, the company's
President and Chief Commercial Officer, will provide a company
overview and commercial update at the H.C. Wainwright Virtual
BioConnect Conference that will be held January 11 - 14, 2021.
The presentation will be available on-demand through the H.C.
Wainwright conference portal, starting at 6:00 AM EST on
Monday, January 11, 2021. An archived
webcast will also be accessible for other viewers in the Media and
Events section of IRRAS' website at
https://www.irras.com/media-events/.
About IRRAS
IRRAS is a global medical care company focused on delivering
innovative medical solutions to improve the lives of critically ill
patients. IRRAS designs, develops, and commercializes neurocritical
care products that transform patient outcomes and decrease the
overall cost of care by addressing complications associated with
current treatment methodologies. IRRAS markets and sells its
comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring
product lines to hospitals worldwide through its direct sales
organization in the United States
and select European countries as well as an international network
of distribution partners.
IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in
Munich, Germany, and San Diego, California, USA. For more
information, please visit www.irras.com.
IRRAS is listed on Nasdaq Stockholm (ticker: IRRAS).
For more information, please contact:
USA
Kleanthis G. Xanthopoulos,
Ph.D.
CEO
ir@irras.com
Europe
Sabina Berlin
CFO
+46 73 951 95 02
sabina.berlin@irras.com
The information was released for public disclosure, through
the agency of the contact person above, on January 5, 2021 at 10:00 (CET).
This information was brought to you by Cision
http://news.cision.com
View original
content:http://www.prnewswire.com/news-releases/irras-to-present-at-hc-wainwright-virtual-bioconnect-conference-301200856.html
SOURCE IRRAS